This document discusses recent advances to overcome antibiotic resistance. It begins with an introduction to antibiotic resistance and defines some superbugs. It then discusses the history of antibiotics from Ehrlich discovering chemotherapy to current generations. Common causes and modes of resistance are described. New classes of antibiotics are discussed like oxazolidinones, glycopeptides, ketolides, glycylcyclines, carbapenems, and cephalosporins. New targets for next generation drugs and possible solutions to antibiotic resistance are also presented.
This presentation give you a brief sight about the exams in pharmacy which are very important for better career. It give information about GPAT and NIPER exams.
COMPLAINTS
TOPIC COVERED
1.Definition
2.Principle
3.Need for complaint handling system
4.Objectives
5.Responsibility
6.Type of complaints (CRITICAL,MAJOR ,MINOR)
7.Key for handling complaint
8.Content of product complaint data sheet
9.Steps involved in handling of complaint
10.Recordings of complain
This presentation give you a brief sight about the exams in pharmacy which are very important for better career. It give information about GPAT and NIPER exams.
COMPLAINTS
TOPIC COVERED
1.Definition
2.Principle
3.Need for complaint handling system
4.Objectives
5.Responsibility
6.Type of complaints (CRITICAL,MAJOR ,MINOR)
7.Key for handling complaint
8.Content of product complaint data sheet
9.Steps involved in handling of complaint
10.Recordings of complain
In a welcome move, the Pharmacy Council of India has recently re-structured the syllabus of the
Bachelor of Pharmacy course. In the effort to make the content more relevant to the practice of
pharmacy in its current form, we now find new, important subjects introduced, and Pharmaceutical
Quality Assurance is one of them.
Basic principles of chemotherapy/ AMAs covers definition, history of AMAs development, principles of AMAs, problems associated with AMAs, failure of therapy with examples.
CANCER: A group of disease involving abnormal cell growth with the potential to invade or spread to other part of the body.
CHEMOTHERAPY: the term chemotherapy is describe as the use of chemicals or drugs to treat cancer.
CYTOTOXIC DRUG: lysis both normal and cancer cells
FLOW OF THE SEMINAR
1. Definition – antibiotic resistance, Multi-resistance, cross-resistance in antibiotics
2. Evolution of resistance
3. Impact of resistance
4. The scenario of resistance: Global, India
5. Factors causing resistance
6. Mechanisms of resistance: Intrinsic and Acquired
7. Acquired mechanism of resistance
8. Quorum sensing
9. Mechanism of resistance in commonly used antibiotics
10. Methods for determining the resistance
11. Strategies to contain resistance
12. Antibiotic stewardship
13. Role of Pharmacologist
14. Initiatives undertaken by India to control resistance
In a welcome move, the Pharmacy Council of India has recently re-structured the syllabus of the
Bachelor of Pharmacy course. In the effort to make the content more relevant to the practice of
pharmacy in its current form, we now find new, important subjects introduced, and Pharmaceutical
Quality Assurance is one of them.
Basic principles of chemotherapy/ AMAs covers definition, history of AMAs development, principles of AMAs, problems associated with AMAs, failure of therapy with examples.
CANCER: A group of disease involving abnormal cell growth with the potential to invade or spread to other part of the body.
CHEMOTHERAPY: the term chemotherapy is describe as the use of chemicals or drugs to treat cancer.
CYTOTOXIC DRUG: lysis both normal and cancer cells
FLOW OF THE SEMINAR
1. Definition – antibiotic resistance, Multi-resistance, cross-resistance in antibiotics
2. Evolution of resistance
3. Impact of resistance
4. The scenario of resistance: Global, India
5. Factors causing resistance
6. Mechanisms of resistance: Intrinsic and Acquired
7. Acquired mechanism of resistance
8. Quorum sensing
9. Mechanism of resistance in commonly used antibiotics
10. Methods for determining the resistance
11. Strategies to contain resistance
12. Antibiotic stewardship
13. Role of Pharmacologist
14. Initiatives undertaken by India to control resistance
Antibiotics and similar drugs, together called antimicrobial agents, have been used for the last many years to treat patients who have infectious diseases. The treatment of bacterial infections is increasingly complicated because microorganisms can develop resistance to antimicrobial agents, since the first usage of antimicrobials, the resistance among bacteria has progressively increased and has accelerated within the last 10 years. This is largely due to the increasing presence of pathogenic microorganisms with resistance to previous antibiotic agents, resulting in the administration of improper treatment, not only in humans but also in companion and food animals and the environment which has caused the rise in antibiotic resistance. Although efforts are being made in all the areas, there is an urgent need to increase the effectiveness of these interventions or some bacterial infections will become difficult if not impossible to treat reliably.
Current techniques and future directions in antibiotic resistance breakersAI Publications
A phenolic molecule found in the curry plant, curcumin, has numerous pharmacological actions, including an antibacterial impact. An environmental, nontuberculous, rapidly growing mycobacterium known as Mycobacterium abscessus is emerging as a serious human pathogen, especially in lung infections, as it possesses broad‐spectrum resistance to antibiotics, possesses a high level of biofilm capability, and has a low prevalence of disease. To identify antimicrobial and antivirulence activity, the researchers wished to examine the antimicrobial and antivirulence activity of curcumin, as well as the ability to work together with medications against a clinical specimen from a lady admitted to hospital with suspected tuberculosis. While strain B developed resistance to amikacin, clarithromycin, ciprofloxacin, and linezolid, strain B exhibited synergism (fractional inhibitory concentration index <0.5) with curcumin, indicating resistance to amikacin, clarithromycin, ciprofloxacin, and linezolid. Inhibiting 4‐ and 8‐day mature biofilms completely with 1/8 MIC curcumin was enough to greatly limit motility. When used together, curcumin and amikacin reduced microbial aggregation while also causing considerable cell death. The main effect found when curcumin was the dominating compound was the disruption of 4- and 8-day biofilms. The current findings confirm prior research that suggests that curcumin may be a resistance buster against antibiotics.
ANTIMICROBIAL RESISTANCES: THE WORLD’S NEXT PANDEMIC ON THE WAYIAEME Publication
Antimicrobial Resistances that lead to increase in duration of curing infections. Drug resistance is the ability of microbes to grow in presence of chemical molecule that are usually meant to kill or inhibit the growth of microbes. This paper reviews antibacterial resistances in E. coli and genes responsible for this resistance. As this is a major problem causing common infection among public. This paper also focuses on the causes of resistance in E. Coli and ways the infection spreads in community. Discovery of antibiotics is a weapon in the war against microbes but now the efficiency of the weapon has reduced. Counter actions are required for war against microbial resistances.
An Impact of Biofield Treatment: Antimycobacterial Susceptibility Potential U...albertdivis
The aim was to evaluate the impact of biofield treatment modality on mycobacterial strains in relation to antimycobacterials susceptibility. Mycobacterial sensitivity was analysed using 12 B BACTEC vials on the BACTEC 460 TB machine in 39 lab isolates (sputum samples) from stored stock cultures.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAkankshaAshtankar
MIP 201T & MPH 202T
ADVANCED BIOPHARMACEUTICS & PHARMACOKINETICS : UNIT 5
APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS By - AKANKSHA ASHTANKAR
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
The Gram stain is a fundamental technique in microbiology used to classify bacteria based on their cell wall structure. It provides a quick and simple method to distinguish between Gram-positive and Gram-negative bacteria, which have different susceptibilities to antibiotics
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
1. Recent Advances to overcome
Antibiotic Resistance
Dr.Akhilesh
M-5698
M.V.Sc Scholar
VETERINARY MEDICINE
2. Contents
Introduction
History
Common causes
Common modes of AR
Most resistant pathogens
Newer antibacterials
New Targets for the Next Generation of Antimicrobial drugs
Possible Solutions for Antibiotic Resistance
3. Introduction
Antimicrobial resistance (AMR) is the ability of a
microorganism to stop an antimicrobial from working against
it. As a result, standard treatments become ineffective,
infections persist and may spread to others.
Antibiotic / Antimicrobial resistance is the ability of microbes
to resist the effects of drugs.
The ability of pathogens that works against the antibiotics, is
termed Antibiotic Resistance.
[1]
(1. www.who.int/drugresistance/en/)
4. Superbug
An informal term for a bacterium that has become resistant
to antibiotics that usually are used to treat it.
Ex:Methicillin-resistant Staphylococcus aureus (MRSA)
Vancomycin-resistant Enterococcus (VRE)
(Rakel RE and Rakel D,2015 )
(Fri, Sep 16,2016)
5. History
PAUL EHRLICH
Coined the term “CHEMOTHERAPY”
Discovered Salvarsan (for Syphilis)
FATHER OF CHEMOTHERAPY
He used the term ‘MAGIC BULLETS’
(Stefan H. E. Kaufmann,2008)
7. …..history
Domagk discovered “Sulphonamides”
Selman Waksman discovered
“Streptomycin”
In 1947, “chloramphenicol” was first used
clinically to treat Typhus
G.Brotzu discovered “Cephalosporins”
Benjamin M. Duggar isolated
“Chlortetracycline” from a mud sample
obtained from a river in Missouri.
8. …..history
1960 onwards second generation
antibiotics like “Methicillin” were
discovered
Following this, semi synthetic derivatives
of older antibiotics with more desirable
properties & different spectrum of activity
were produced
e.g. Fluroquinolones, Oxazolidinones etc.
16. Why do we need newer antimicrobials
Bacterial resistance to antimicrobials-
health and economic problem
Chronic resistant infections contribute to
increasing health care cost
Increase morbidity & mortality
with resistant microorganisms
[D.M. Livermore ,Clinical Microbiology & Infection
Volume 10, Supplement 4, Pages 1-36 (2004)]
17.
18. Oxazolidinones
Considered to be the first truly new
class of antibacterial drugs introduced in
the past 3 decades
Linezolid
Approved for adults use in 2000
Approved for pediatric
use in 2005
20. Mechanism of Resistance to
older Oxazolidinones
Occurs due to mutations in ribosomal RNA
(rRNA)
Resistance overcome by:
Newer oxazolidinones by additional
hydrogen bond interactions with 23S rRNA
(Jaswant Rai et al, 2013)
21. Newer glycopeptides
Vancomycin & Teicoplanin are already in
use
Recently APPROVED DRUG
Telavancin :Approved in 2009 for complicated
skin and skin structure infections(MRSA)
DRUGS IN PIPELINE
Oritavancin : Phase III trial
Dalbavancin : Phase III trial
22. Mechanism of resistance to older
glycopeptides.
Synthesis of low-affinity precursors in
which C-terminal D-Ala residue is replaced
by:
D-lactate (D-Lac) or by D-serine (D-Ser)
Resistance overcome by:
High binding affinity for both substrates
(D-Ala-D-Lac precursor substrate OR D-
Ala-D-Ser) due to presence of
hydrophobic side chain. (Mandeep Kaur et al,2014)
23. Ketolides
Drug resistance in community acquired
respiratory tract infections discovery
and development of ketolides.
Carbonyl group at the C3 position, responsible for
sensitivity to macrolide resistant strains.
24. Newer ketolides
APPROVED DRUG
Telithromycin –Approved in 2004
DRUGS IN PIPELINE
Cethromycin- Phase III trails
Solithromycin – Phase III trails
26. Glycylcyclines
New class of antibiotic derived from
tetracycline
Designed to overcome two common mechanisms
of tetracycline resistance
Resistance mediated by acquired efflux pumps
Ribosomal protection
Only one glycylcycline antibiotic for
clinical use : TIGECYCLINE
(Frampton JE & Curran MP, Tigecycline Drugs,2005)
27. Newer Carbapenems
Beta-lactum antibiotics with a broad
spectrum of antibacterial activity
NEWER CARBAPENEMS :
Ertapenem : Approved in 2001
Doripenem : Approved in 2007
DRUG IN PIPELINE :
Razupenem : Phase II clinical trail
(Livermore DM, Mushtaq S, Warner M, 2009)
28. Newer Cephalosporins
Approved Cephalosporins
Ceftaroline: Approved in 2010
For the treatment of
o Community – acquired pneumonia
o Complicated skin and soft – tissue
infections
Drugs in pipeline
Ceftobiprole : awaiting FDA approval
(Saravolatz LD et al, 2011)
29. New Targets for the Next
Generation of Antimicrobial drugs
Targeting virulence factors
Targeting bactericidal functions of
bacterial proteins
Modulating host response pathways
Peptides derived from vertebrates,
invertebrates and microorganism.
(Gurpreet Kaur Randhawa et al, 2013)
30.
31.
32.
33.
34.
35.
36. Possible Solutions for Antibiotic
Resistance
Stop unnecessary antibiotic prescriptions.
Finish antibiotic prescriptions.
Use the right antibiotic in an infectious situation
as determined by antibiotic sensitivity testing.
Use antibiotics in rotation.
Use combination of antibiotics if necessary.
Promote Vaccine recommendations.
Implement infection control measures, such
as hand washing, isolation precautions, and
immunization.
Improve communication, education and training.
37. Conclusion
There is a great need of newer antibiotics
because of increasing microbial resistance
Because of increase cost of development
and increasing resistant, only few drugs
are in pipeline
Some of the newer agents are effective
against resistant strains
Programs like Antibiotic stewardship can
be helpful to combat the resistance
Rational use of antibiotics remains the
most important measure.
38. References
www.who.int/drugresistance/en/
www.cdc.gov › Antibiotic / Antimicrobial Resistance › U.S.
Activities to Combat AR
http://www.sciencedaily.com/articles/a/antibiotic_resistanc
e.html
Andrea Gyyot, Graham Layer,2006 MRSA Bugbear of a surgical
practice reducing the incidence of MRSA surgical site infection,
Ann R Coll Surg Engl: 88: 222-223.
Archibald L(1997).Antimicrobial resistance in isolates from
inpatients and outpatients in the United States: increasing
importance of the intensive care unit. Clinical Infectious Diseases.
24(2):211-215
Ceasr A, Arias, M.D. and Balbara E. Murray, M.D.N., 2009.
Antibiotic resistant Bugs in the 21st Century. A clinical super
challenge. Eng. J. Med.: 360: 439-443
39. Microbiology, A clinical Approach -Danielle Moszyk-Strelkauskas-
Garland Science 2010
Jaswant Rai, Gurpreet Kaur Randhawa, and Mandeep Kaur,
Recent advances in antibacterial drugs, Int J Appl Basic Med
Res. 2013 Jan-Jun; 3(1): 3–10.
D.M. Livermore ,Clinical Microbiology & Infection Volume
10, Supplement 4, Pages 1-36 (2004)
Vikas Manchanda, Sinha Sanchaita, and NP Singh J. Glob
Infect Dis. 2010 Sep-Dec; 2(3): 291–304.
Losee L. Ling et al, A new antibiotic kills pathogens without
detectable resistance, Journal Nature 517, 455–459 (22 January
2015)